OOIR: Observatory of International Research

Papers

(The H4-Index of Cellular & Molecular Biology Letters is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	189
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	168
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	135
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	116
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	114
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	107
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	105
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges	96
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis	94
lncRNA PVT1: a novel oncogene in multiple cancers	93
Osteoporosis pathogenesis and treatment: existing and emerging avenues	78
Melatonin and cancer suppression: insights into its effects on DNA methylation	71
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L	68
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells	63
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo	61
COVID-19 therapies: do we see substantial progress?	60
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation	58
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress	55
Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma	53
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration	42
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner	40
RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop	39
Diversification of PAR signaling through receptor crosstalk	39
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications	38
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30	36

Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage	36
The role of macrophage subtypes and exosomes in immunomodulation	35
The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability	34
LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability	34
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer	33
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid	32
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer	32
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress	32